Crossmark

A Review of Utility Measurement Methods Used in Pharmacoeconomic Submissions to HIRA in South Korea: Methodological Consistency and Areas for Improvement

Crossref DOI link: https://doi.org/10.1007/s40273-021-01066-x

Published Online: 2021-07-28

Published Print: 2021-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hong, Jihyung

Bae, Eun-Young
Funding

Funding for this research was provided by:

Health Insurance Review and Assessment Service (제2019-166호)
License Information

Text and Data Mining valid from 2021-07-28

Version of Record valid from 2021-07-28
More Information

Article History

Accepted: 4 July 2021

First Online: 28 July 2021

Declarations

:

: This work was supported by the Health Insurance Review and Assessment Service.

: Jihyung Hong and Eun-Young Bae were previously (EB) or are currently (JH) members of the Economic Subcommittee at HIRA. The authors declare no conflict of interest that are directly relevant to the content of this article.

: Not applicable.

: Not applicable.

: Not applicable.

: The data that support the findings of this study are available within the article or its supplementary material. Request for access to full copies of manufacturers’ PE submissions should be made directly to HIRA, not the authors.

: Not applicable.

: JH and EB made the study design together. JH drafted this manuscript, and EB provided a critical review of this manuscript.

Document is current

Any future updates will be listed below